Zika Virus Testing Market

Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don?t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections. Zika virus testing is recommended only for certain people. People live in or traveled to an area with risk of Zika; People had sex without a condom with a partner who lives in or traveled to an area with risk of Zika; Pregnant women who don?t have Zika symptoms lives in or traveled to an area with risk of Zika.
Zika Virus Testing Market contains market size and forecasts of Zika Virus Testing in Global, including the following market information:
Global Zika Virus Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Zika Virus Testing market was valued at 119.4 million in 2021 and is projected to reach US$ 146.5 million by 2028, at a CAGR of 3.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Molecular Test Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Zika Virus Testing include Chembio, Quest Diagnostics, ARUP Laboratories, Luminex, Simens, Abbott Molecular, Hologic, ELITech Molecular Diagnostics and EUROIMMUN US, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Zika Virus Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Zika Virus Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Zika Virus Testing Market Segment Percentages, by Type, 2021 (%)
Molecular Test
Serologic Test
Global Zika Virus Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Zika Virus Testing Market Segment Percentages, by Application, 2021 (%)
Diagnostic Centers
Hospitals
Pathology Labs
Global Zika Virus Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Zika Virus Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Zika Virus Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Zika Virus Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Chembio
Quest Diagnostics
ARUP Laboratories
Luminex
Simens
Abbott Molecular
Hologic
ELITech Molecular Diagnostics
EUROIMMUN US
Creative Diagnostics
Vela Diagnostics
InBios International
Primerdesign
Altona Diagnostics